Current Scenario in Anti-Microbial Therapy and Emerging Treatment in Diabetic Foot Ulcer
DOI:
https://doi.org/10.31033/ijrasb.9.1.11Keywords:
Foot ulcer, Wound healing, Management, Inflammation, DiabeticAbstract
Diet-related complications such as diabetic foot ulcers are the leading cause of death for diabetics. In clinical studies, a wide variety of medications from various pharmacological families are being used to treat diabetic foot ulcers, but only a few have received regulatory approval. Diabetic foot ulcers are caused by a variety of factors, including neuropathy, peripheral artery disease, infection, gender, smoking, and age. Bacterial resistance to present medications is a problem in the treatment of diabetic foot ulcers. For diabetic foot ulcers, this study focuses on the existing treatment, the current treatment method, and potential pharmaceutical targets. Rather of relying on a single medicine to cure a diabetic foot ulcer, a combination of therapy is the best option because several factors contribute to its development. These studies show that treating diabetic foot ulcers in the absence of routine access to laboratory or radiographic testing is possible despite the various challenges that practitioners confront around the world. DFUs are becoming a more important public health problem as they become more prevalent. Because of the difficulty in distinguishing between infection and colonisation in DFU, MDR bacteria have arisen as an issue. In addition, DFU develops biofilms on the skin's outer surface. Biofilm complicates the pathophysiology of DFU and can impede healing. Antibiotic-resistant conditions, such as those caused by biofilm-forming bacteria and MDR bacteria, can lead to chronic wounds, infection, and even lower-limb amputation. In this case, antibiotic alternatives would be very appreciated in the treatment of DFU. Antibiofilm approaches, which can prevent the production of microbial biofilms as well as wound chronicity, are among the creative alternative treatments for the management of DFU wounds that are discussed in this study. DFU can be treated more quickly and effectively if these cutting-edge therapeutic options are used instead of or in conjunction with more established methods.
Downloads
References
Canadian Diabetes Association. Diabetes Statistics in Canada. 2006. Available from: www. diabetes.ca/how-you-can-help/advocate/why-federal-leadership-is-essential/diabetesstatistics-in-canada.
Canadian Institute for Health Information (CIHI). Compromised Wounds: Costly and a System-wide Problem. August 2013.
Palumbo PJ, Melton LJ III. Peripheral vascular disease and diabetes. In: Diabetes in America: Diabetes Data. Government Printing Office, Washington. 1985.
Armstrong DG, Holtz-Neiderer K, Wendel C, Mohler MJ, Kimbriel HR, Lavery LA. Skin temperature monitoring reduces the risk for diabetic foot ulceration in high-risk patients. Am J Med. 2007;120(12):1042–1046.
Narayan KMV, Zhang P, Kanaya AM, Williams DE, Engelgau MM, Imperatore G, et al. Diabetes: The pandemic and potential solutions. In: Disease Control Priorities in Developing Countries (2nd edition). New York: Oxford University Press; 2006.
Schoen C, Osborn R, Huynh PT, Doty M, Zapert K, Peugh J, et al. Taking the pulse of health care systems: Experiences of patients with health problems in six countries. Health Aff (Millwood). 2005;Suppl Web Exclusives:W5–509–25.
Cheung C, Alavi A, Botros M, Sibbald RG, Queen D. The diabetic foot: A reconceptualization. Diabetic Foot Canada. 2013;1(1):11–12.
Roshan kumar, Purabi Saha, Yogendra kumar, Soumitra Sahana, Anubhav Dubey, Om prakash. A Review on Diabetes Mellitus: Type1 & Type 2 . World Journal of Pharmacy and Pharmaceutical science.2020; 9(10):838-850.
Roshan kumar, Purabi Saha, Yogendra kumar, Soumitra Sahana, Binita kumari, Rakesh Kumar Arya. Cascuta Reflexa A critical Review on Medicinal Plant used in Ayurveda.World Journal of Pharmacy and Pharmaceutical science.2020; 9(10):1134-1145.
Roshan kumar, Purabi Saha, Yogendra kumar, Soumitra Sahana, Binita kumari, Rakesh Kumar Arya, Abhishek kumar,Vishnu Mittal,Sahenur Begum, Sibam padhy. Cassia Sophera Linn. A Review on Ayurvedic Medico.World Journal of Pharmacy and Pharmaceutical science.2020; 9(11):496-503.
Registered Nurses’ Association of Ontario (RNAO). Clinical Best Practice Guidelines: Assessment and Management of Foot Ulcers for People with Diabetes (2nd Edition). 2013.
Kuhnke JL, Botros M, Elliot J, Rodd-Nielsen E, Orsted H, Sibbald RG. The case for diabetic foot screening. Wound Care Canada. 2013;1(2):1–7.
Lowe J, Sibbald G, Taha NY, Lebovic G, Rambaran M, Martin C, et al. The Guyana diabetes and foot care project: Improved diabetic foot evaluation reduces amputation rates by two-thirds in a lower middle income country. International Journal of Endocrinology. 2015(2015):920124.
Orsted HL, Botros M. Inlow’s 60-Second Diabetic Foot Screen gets a new look! Wound Care Canada. 2018;16(1):26–29.
Woodbury MG, Sibbald RG, Ostrow B, Persaud R, Lowe JM. Tool for rapid & easy identification of high risk diabetic foot: Validation & clinical pilot of the simplified 60 second diabetic foot screening tool. PLoS One. 2015;10(6):e0125578.
Canadian Diabetes Association Clinical Practice Guidelines Expert Committee. Canadian Diabetes Association Clinical Practice Guidelines. Canadian Journal of Diabetes. 2013;37(S1):S1–S212. Available from: http://guidelines.diabetes.ca/app_themes/cdacpg/ resources/cpg_2013_full_en.pdf
Driver V, LeBretton JM, Allen L, Park NJ. Neuropathic wounds; The diabetic wound. In: Bryant RA, Nix DP (eds.). Acute and Chronic Wounds: Current Management Concepts (5th edition). St. Louis, Missouri: Elsevier; 2016. p. 239–262.
Public Health Agency of Canada. Reducing the risk of type 2 diabetes and its complications. In: Diabetes in Canada: Facts and Figures from a Public Health Perspective. In: Diabetes in Canada: Facts and Figures from a Public Health Perspective. 2011.
Orsted HL, Searles G, Trowell H, et al. Best practice recommendations for the prevention, diagnosis and treatment of diabetic foot ulcers: Update 2006. Wound Care Canada. 2006;4(1):57–71.
Hinchliffe RJ, Brownrigg JRW, Apelqvist J, EBoyko EJ, Fitridge R, Mills JL, et al. IWGDF Guidance on the Diagnosis, Prognosis and Management of Peripheral Artery Disease in Patients with Foot Ulcers in Diabetes. 2015. Available from: www.iwgdf.org/files/2015/ website pad.pdf.
Strauss M, Barry D. Vascular assessment of the neuropathic foot. J Prosth Orthot. 2005;17(2S):35–37.
Registered Nurses’ Association of Ontario (RNAO). Nursing Best Practice Guideline: Assessment and Management of Foot Ulcers for People with Diabetes. Toronto, ON: RNAO, 2005. 23.
Canadian Association of Wound Care. Advances for the Management of Diabetic Foot Complications. Session workbook. 2016.
Alavi A, Sibbald RG, Nabavizadeh R, Valaei F, Coutts P, Mayer D. Audible handheld Doppler ultrasound determines reliable and inexpensive exclusion of significant peripheral arterial disease. Vascular. 2015;23(6):622–629.
Bus SA, van Netten JJ, Lavery LM, Monteiro-Soares M, Rasmussen A, Jubiz Y, et al. IWGDF Guidance on the Prevention of Foot Ulcers in At-Risk Patients with Diabetes. 2015.
Hingorani A, LaMuraglia GM, Henke P, Meissner MH, Loretz L, Zinszer KM, et al. The management of diabetic foot: A clinical practice guideline by the Society for Vascular Surgery in collaboration with the American Podiatric Medical Association and the Society for Vascular Medicine. J Vasc Surg. 2016;63(2):3S–21S.
Bus SA, Maas M, Cavanagh PR, Michels RP, Levi M. Plantar fat-pad displacement in neuropathic diabetic patients with toe deformity: A magnetic resonance imaging study. Diabetes Care. 2004;27(10):2376–2381.
Nubé VL, Molyneaux L, Yue DK. Biomechanical risk factors associated with neuropathic ulceration of the hallux in people with diabetes mellitus. J Am Podiatr Med Assoc. 2006;96(3):189–197.
ElMakki AM, Tamimi AO, Mahadi SI, Widatalla AH, Shawer MA. Hallux ulceration in diabetic patients. J Foot Ankle Surg. 2010;49(1):2–7.
Barua RS, Sy F, Srikanth S, et al. Effects of cigarette smoke exposure on clot dynamics and fibrin structure: an ex vivo investigation. Arterioscler Thromb Vasc Biol. 2010;30(1):75–79. doi:10.1161/ATVBAHA.109.19.
Abbas M, Uckay I, Lipsky BA. In diabetic foot infections antibiotics are to treat infection, not to heal wounds. Expert Opin Pharmacother. 2015;16(6):821–832. doi:10.1517/14656566.2015.1021780
Uçkay I, Aragón-Sánchez J, Lew D, Lipsky BA. Diabetic foot infections: what have we learned in the last 30 years? Int J Infect Dis. 2015;40:81–91. doi:10.1016/j.ijid.2015.09.023
Ginsburg I, van Heerden PV, Koren E. From amino acids polymers, antimicrobial peptides, and histones, to their possible role in the pathogenesis of septic shock: a historical perspective. J Inflamm Res. 2017;10:7. doi:10.2147/JIR.S126150
Reddy K, Yedery R, Aranha C. Antimicrobial peptides: premises and promises. Int J Antimicrob Agents. 2004;24(6):536–547. doi:10.1016/j.ijantimicag.2004.09.005
Jin G, Weinberg A. Human antimicrobial peptides and cancer. Semin Cell Dev Biol. 2019;88:156–162. Elsevier. doi:10.1016/j.semcdb.2018.04.006
Nader HB, Buonassisi V, Colburn P, Dietrich CP. Heparin stimulates the synthesis and modifies the sulfation pattern of heparan sulfate proteoglycan from endothelial cells. J Cell Physiol. 1989;140(2):305–310. doi:10.1002/jcp.1041400216
Jörneskog G, Brismar K, Fagrell B. Low molecular weight heparin seems to improve local capillary circulation and healing of chronic foot ulcers in diabetic patients. VASA Zeitschrift fur Gefasskrankheiten. 1993;22(2):137.
Ma C, Hernandez MA, Kirkpatrick VE, Liang L-J, Nouvong AL, Gordon II. Topical platelet-derived growth factor vs placebo therapy of diabetic foot ulcers offloaded with windowed casts: a randomized, controlled trial. Wounds. 2015;27(4):83–91.
Fan H, Yu J, Cui G, Zhang W, Yang X, Dong Q. Insulin pump for the treatment of diabetes in combination with ulcerative foot infections. J Biol Regul Homeost Agents. 2016;30(2):465–470.
Adeghate J, Nurulain S, Tekes K, Fehér E, Kalász H, Adeghate E. Novel biological therapies for the treatment of diabetic foot ulcers. Expert Opin Biol Ther. 2017;17(8):979–987.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2022 International Journal for Research in Applied Sciences and Biotechnology
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
editor@ijrasb.com 